Featured Article
DaVita, a kidney care provider primarily serving the United States, had a positive FY 2024. Revenue rose 5.6% to $12.8 billion, and operating profits rose 30% to $2.1 billion over last year. A review of DaVita’s 13 February 2025 earnings call and associated financial reports provided insight regarding the importance of pricing on performance. FACTS FROM EARNINGS CALL AND ANNUAL REPORT Javier Rodriguez, CEO of DaVita, sent mixed signals about revenue drivers.…
In This Issue
“Traditionally, the large, multinational corporation was held together by ownership. Today, it is held together by a strategic purpose. Ownership of the…
People like crystal balls that predict the future. They publicly lament and place blame on potential causes when the crystal balls offer…
At the Spintelligent Metering, Billing, CRM/CIS Americas conference held in Chicago, IL during May 2003, over 450 registered attendees were treated to…
Building energy efficient buildings has been a pursuit of many ecology minded activist and architects, but economics has driven the market towards…